Opioid Consumption After Discharge from Total Knee and Hip Arthroplasty: A Systematic Review and Meta-Analysis

BackgroundPain is challenging after recovery from total knee arthroplasty (TKA) and total hip arthroplasty (THA) procedures, and patients often receive prescription opioids. However, opioid consumption by patients remains unclear, and unused opioids may lead to risks including misuse and diversion. The objective of this systematic review and meta-analysis was to compare prescription size versus patient-reported consumption of opioids after discharge following TKA and THA.MethodsPubMed and EMBASE were systematically searched for publications published between 2015 to 2022 on patient-reported consumption of opioids after TKA and THA. The primary outcome was opioid use in oxycodone 5 mg equivalents. Team members independently reviewed studies for screening, inclusion, data extraction, and risk of bias.ResultsAmong the 17 included studies (15 TKA and 11 THA), discharge opioid prescribing exceeded consumption for both TKA (88.4 versus 65.0 pills at 6 weeks) and THA (64.0 versus 29.8 pills at 12 weeks). For both TKA and THA, the range of opioids prescribed varied significantly, by 1.6-fold for TKA and 2.8-fold for THA. Most studies reported pain outcomes (89%) and the use of non-opioid medications (72%). Of the four studies offering prescribing recommendations, the amounts ranged from 50 to 104 pills for TKA and 30 to 45 pills for THA.ConclusionsOpioid prescribing exceeds the amount consumed following TKA and THA. These findings serve as a call to action to tailor prescribing guidelines to how much patients actually consume while emphasizing the use of non-opioid medications in order to better optimize recovery from surgery.